Skip to content

Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent

Prospective Evaluation of the Clinical Utility of Pseudocyst Drainage With Metal Stent

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01239056
Enrollment
22
Registered
2010-11-11
Start date
2009-08-31
Completion date
2015-05-31
Last updated
2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Pseudocysts

Brief summary

The purpose of this study is to study the evaluation of the effectiveness of endoscopic Pancreatic Pseudocyst drainage using a metal stent.

Interventions

PROCEDUREEndoscopy

Endoscopic drainage of a pancreatic pseudocyst using a metal stent per medical indication.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject is 18 years or older 2. Subject has pancreatic pseudocyst 3. Subject has medical indication for drainage of the pancreatic pseudocyst 4. Subject must be able to give informed consent

Exclusion criteria

1. Any contraindication to endoscopic pseudocyst drainage 2. Subject is unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Technical Success of Endoscopic Ultrasound-guided Single-access Pseudocyst Drainage With a Fully Covered Self-expanding Metal Stent ; Anchored With a Double Pigtail Plastic Stent Inserted Through the Metal Stent LumenbaselineTechnical success was evaluated by the ability to achieved pseudocyst drainage after endoscopically placing a Fully Covered Self-expanding Metal Stent in the pseudocyst . Technical failure was evaluated by the inability to fully drain the pancreas pseudocyst after endoscopically placing a Fully Covered Self-expanding Mental Stent in the pseudocyst.

Secondary

MeasureTime frame
Resolution of Pancreatic Pseudocyst After Placement of Fully Covered Self-expanding Metal Stent (CSEMS).6 to 12 weeks after baseline
Adverse Events1 year

Countries

United States

Participant flow

Pre-assignment details

There were 22 signed informed consents, however after Endoscopic ultrasound imaging, 2 participants were excluded due to characteristics of the cyst cavity. Therefore, 20 participants underwent transgastric drainage of pancreatic pseudocysts by use of the fully covered self-expanding metal stents (CSEMS).

Participants by arm

ArmCount
Pancreatic Pseudocysts
Patients underwent Endoscopic Ultrasound-guided pseudocyst transmural drainage using fully covered self-expanding metal stents (CSEMS). Next, patients underwent an Endoscopic retrograde cholangiopancreatography to evaluate for Pancreatic duct (PD) disruption. Patients then received an abdominal CT to assess pancreatic pseudocyst resolution. If complete resolution was noted, all stents were subsequently removed. If the pseudocyst was not resolved, stent removal was deferred and follow-up CTs were obtained at 2 to 4 week intervals until radiographic resolution was achieved.
20
Total20

Baseline characteristics

CharacteristicPancreatic Pseudocysts
Age, Continuous57 years
Pseudocyst diameter13.4 centimeters
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 20
serious
Total, serious adverse events
2 / 20

Outcome results

Primary

Technical Success of Endoscopic Ultrasound-guided Single-access Pseudocyst Drainage With a Fully Covered Self-expanding Metal Stent ; Anchored With a Double Pigtail Plastic Stent Inserted Through the Metal Stent Lumen

Technical success was evaluated by the ability to achieved pseudocyst drainage after endoscopically placing a Fully Covered Self-expanding Metal Stent in the pseudocyst . Technical failure was evaluated by the inability to fully drain the pancreas pseudocyst after endoscopically placing a Fully Covered Self-expanding Mental Stent in the pseudocyst.

Time frame: baseline

ArmMeasureGroupValue (NUMBER)
Pancreatic PseudocystsTechnical Success of Endoscopic Ultrasound-guided Single-access Pseudocyst Drainage With a Fully Covered Self-expanding Metal Stent ; Anchored With a Double Pigtail Plastic Stent Inserted Through the Metal Stent Lumentechnical success20 participants
Pancreatic PseudocystsTechnical Success of Endoscopic Ultrasound-guided Single-access Pseudocyst Drainage With a Fully Covered Self-expanding Metal Stent ; Anchored With a Double Pigtail Plastic Stent Inserted Through the Metal Stent Lumentechnical failure0 participants
Secondary

Adverse Events

Time frame: 1 year

ArmMeasureGroupValue (NUMBER)
Pancreatic PseudocystsAdverse EventsPseudocyst infection requiring surgery2 participants
Pancreatic PseudocystsAdverse EventsPosttransmural drainage fever1 participants
Pancreatic PseudocystsAdverse EventsPostEndoscopic retrograde cholangiopancreatography1 participants
Secondary

Resolution of Pancreatic Pseudocyst After Placement of Fully Covered Self-expanding Metal Stent (CSEMS).

Time frame: 6 to 12 weeks after baseline

ArmMeasureGroupValue (NUMBER)
Pancreatic PseudocystsResolution of Pancreatic Pseudocyst After Placement of Fully Covered Self-expanding Metal Stent (CSEMS).Resolution of Pseudocyst17 participants
Pancreatic PseudocystsResolution of Pancreatic Pseudocyst After Placement of Fully Covered Self-expanding Metal Stent (CSEMS).Unresolved Pseudocyst3 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026